A study called the National COVID Cancer Antibody Survey has launched today that will collect COVID antibody data on 10,000 people with cancer. The aim of the study is to understand what protection from COVID the vaccines provide people with cancer and who remains at risk. Participants will be asked to give a blood sample using a finger-prick test which will then get analysed in the lab. Results will be sent back to people who take part.
If you’re over 18, live in England, you’ve been diagnosed with cancer in the last year, or if you’re currently taking cancer treatment, you might be eligible to take part. For more information and to sign up, you can visit www.covidcancersurvey.uk
(If anyone gets an error message when asked if they are in full time work and the answer is ‘no’ please just click continue and it should take you through. The team are trying to rectify this now).
Please note - You may find these blogs helpful to read -